Skip NavigationSkip to Content

Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing

  1. Author:
    Xiao, Wenming
    Ren, Luyao
    Chen, Zhong
    Fang, Li Tai
    Zhao,Yongmei
    Lack,Justin
    Guan, Meijian
    Zhu, Bin
    Jaeger, Erich
    Kerrigan, Liz
    Blomquist, Thomas M.
    Hung, Tiffany
    Sultan, Marc
    Idler, Kenneth
    Lu, Charles
    Scherer, Andreas
    Kusko, Rebecca
    Moos, Malcolm
    Xiao, Chunlin
    Sherry, Stephen T.
    Abaan, Ogan D.
    Chen, Wanqiu
    Chen, Xin
    Nordlund, Jessica
    Liljedahl, Ulrika
    Maestro, Roberta
    Polano, Maurizio
    Drabek, Jiri
    Vojta, Petr
    Koks, Sulev
    Reimann, Ene
    Madala, Bindu Swapna
    Mercer, Timothy
    Miller, Chris
    Jacob, Howard
    Truong, Tiffany
    Moshrefi, Ali
    Natarajan, Aparna
    Granat, Ana
    Schroth, Gary P.
    Kalamegham, Rasika
    Peters, Eric
    Petitjean, Virginie
    Walton,Ashley
    Shen,Tsai-Wei
    Talsania,Keyur
    Vera, Cristobal Juan
    Langenbach, Kurt
    de Mars, Maryellen
    Hipp, Jennifer A.
    Willey, James C.
    Wang, Jing
    Shetty,Jyoti
    Kriga,Yuliya
    Raziuddin,Arati
    Tran,Bao
    Zheng, Yuanting
    Yu, Ying
    Cam, Margaret
    Jailwala, Parthav
    Meerzaman, Daoud
    Chen, Qingrong
    Yan, Chunhua
    Ernest, Ben
    Mehra, Urvashi
    Jensen, Roderick
    Jones, Wendell
    Li, Jian-Liang
    Papas, Brian N.
    Pirooznia, Mehdi
    Chen, Yun-Ching
    Seifuddin, Fayaz
    Li, Zhipan
    Liu, Xuelu
    Resch, Wolfgang
    Wang, Jingya
    Wu, Leihong
    Yavas, Gokhan
    Miles, Corey
    Ning, Baitang
    Tong, Weida
    Mason, Christopher E.
    Donaldson, Eric
    Lababidi, Samir
    Staudt, Louis M.
    Tezak, Zivana
    Hong, Huixiao
    Wang, Charles
    Shi, Leming
  2. Author Address

    US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.Fudan Univ, Sch Life Sci, Human Phenome Inst, State Key Lab Genet Engn, Shanghai, Peoples R China.Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China.Loma Linda Univ, Sch Med, Ctr Genom, Loma Linda, CA 92350 USA.Roche Sequencing Solut Inc, Bioinformat Res & Early Dev, Belmont, CA USA.Frederick Natl Lab Canc Res, Biomed Informat & Data Sci Directorate, Adv Biomed & Computat Sci, Frederick, MD USA.SAS Inst Inc, Cary, NC USA.NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA.Illumina Inc, Foster City, CA USA.ATCC, Manassas, VA USA.Univ Toledo, Med Ctr, Dept Med, Toledo, OH USA.Univ Toledo, Med Ctr, Dept Pathol, Toledo, OH USA.Genentech Inc, San Francisco, CA 94080 USA.Novartis Inst Biomed Res, Biomarker Dev, Basel, Switzerland.AbbVie, Genom Res Ctr, Computat Genom, N Chicago, IL 60064 USA.Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland.European Infrastruct Translat Med, Amsterdam, Netherlands.Immuneering Corp, Cambridge, MA USA.US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA.NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.Seven Bridges Genom Inc, Cambridge, MA USA.Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden.NCI, Ctr Riferimento Oncol Aviano, IRCCS, Unit Oncogenet & Funct Oncogen, Aviano, Italy.Palacky Univ Olomouc, Fac Med & Dent, IMTM, Olomouc, Czech Republic.Perron Inst Neurol & Translat Sci, Perth, WA, Australia.Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Perth, WA, Australia.Univ Tartu, Estonian Genome Ctr, Inst Genom, Tartu, Estonia.Kinghorn Canc Ctr, Garvan Inst Med Res, Darlinghurst, NSW, Australia.Natl Inst Metrol, Beijing, Peoples R China.Frederick Natl Lab Canc Res, Canc Res Technol Program, Sequencing Facil, Frederick, MD USA.Ctr Canc Res, Off Sci & Technol Resources, CCR Collaborat Bioinformat Resource, Bethesda, MD USA.NCI, Computat Genom & Bioinformat Branch, Ctr Biomed Informat & Informat Technol, Rockville, MD USA.Digicon, Mclean, VA USA.Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA.Q2 Solut EA Genom, Morrisville, NC USA.NIEHS, Integrat Bioinformat, Durham, NC USA.NHLBI, Bioinformat & Computat Biol Core, NIH, Bldg 10, Bethesda, MD 20892 USA.Sentieon Inc, Mountain View, CA USA.NIH, Ctr Informat Technol, Bldg 10, Bethesda, MD 20892 USA.AstraZeneca, Gaithersburg, MD USA.US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA.US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.US FDA, Off Chief Scientist, Off Commissioner, Silver Spring, MD USA.NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
    1. Year: 2021
    2. Date: Sep
    3. Epub Date: 2021 Sep 9
  1. Journal: Nature Biotechnology
  2. Nature Portfolio
    1. 39
    2. 9
    3. Pages: 1141-1150
  3. Type of Article: Article
  4. ISSN: 1087-0156
  1. Abstract:

    Recommendations are given on optimal read coverage and selection of calling algorithm to maximize the reproducibility of cancer mutation detection in whole-genome or whole-exome sequencing.

    See More

External Sources

  1. DOI: 10.1038/s41587-021-00994-5
  2. PMID: 34504346
  3. PMCID: PMC8506910
  4. WOS: 000694844000025

Library Notes

  1. Fiscal Year: FY2021-2022
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel